Literature DB >> 20182844

Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging.

Mitsuhiro Tozaki1, Yu Oyama, Eisuke Fukuma.   

Abstract

PURPOSE: The aim of this study was to assess the efficacy of single-voxel (1)H magnetic resonance spectroscopy (MRS) at 1.5 T to evaluate early responses to neoadjuvant chemotherapy after the first treatment in breast cancer patients and to compare it to measurements of apparent diffusion coefficient (ADC) values derived from diffusion-weighted magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Nine patients with breast cancer who were scheduled to receive neoadjuvant chemotherapy were recruited. MR examination after the first cycle was scheduled for a few days before the administration of the second dose.
RESULTS: Two patients were excluded from the study because their regimen was changed after the first cycle. MRS before chemotherapy demonstrated the presence of choline (Cho) at 3.22-3.23 ppm in six cases and at 3.27 ppm in one case. Diffusion-weighted MRI before chemotherapy demonstrated a localized high-signal lesion in all cases. The change of the integral value of Cho after the first cycle of chemotherapy showed a positive correlation with the change in lesion size (r = 0.91, P = 0.01), whereas no correlation was observed between the change of ADC values after the first cycle and the change in lesion size (r = 0.45, P = 0.32).
CONCLUSION: MRS after the first cycle may be more sensitive to diffusion-weighted MRI to predict the pathological response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182844     DOI: 10.1007/s11604-009-0391-7

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  31 in total

1.  MRI of breast cancer: influence of chemotherapy on sensitivity.

Authors:  A Rieber; H Zeitler; H Rosenthal; J Görich; R Kreienberg; H J Brambs; R Tomczak
Journal:  Br J Radiol       Date:  1997-05       Impact factor: 3.039

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  In vivo diffusion-weighted MRI of the breast: potential for lesion characterization.

Authors:  Shantanu Sinha; Flora Anne Lucas-Quesada; Usha Sinha; Nanette DeBruhl; Lawrence W Bassett
Journal:  J Magn Reson Imaging       Date:  2002-06       Impact factor: 4.813

4.  Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate.

Authors:  P S Murphy; M O Leach; I J Rowland
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

5.  Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration.

Authors:  Bonnie N Joe; Victoria Y Chen; Nouha Salibi; Pornpim Fuangtharntip; Charles F Hildebolt; Kyongtae T Bae
Journal:  Invest Radiol       Date:  2005-07       Impact factor: 6.016

6.  MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation.

Authors:  P T Weatherall; G F Evans; G J Metzger; M H Saborrian; A M Leitch
Journal:  J Magn Reson Imaging       Date:  2001-06       Impact factor: 4.813

7.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

Authors:  Sina Meisamy; Patrick J Bolan; Eva H Baker; Robin L Bliss; Evin Gulbahce; Lenore I Everson; Michael T Nelson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood
Journal:  Radiology       Date:  2004-11       Impact factor: 11.105

8.  Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography.

Authors:  Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Toshihiro O'uchi; Naoko Kawano; Takako Suzuki; Norie Yamashiro; Shinji Ozaki; Naomi Sakamoto; Kuniki Higa; Satoko Abe; Tomoko Ogawa; Eisuke Fukuma
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

9.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Authors:  B Fisher; J Bryant; N Wolmark; E Mamounas; A Brown; E R Fisher; D L Wickerham; M Begovic; A DeCillis; A Robidoux; R G Margolese; A B Cruz; J L Hoehn; A W Lees; N V Dimitrov; H D Bear
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

10.  Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.

Authors:  Peter Stanwell; Laurence Gluch; David Clark; Boguslaw Tomanek; Luke Baker; Bruno Giuffrè; Cynthia Lean; Peter Malycha; Carolyn Mountford
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

View more
  19 in total

1.  MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.

Authors:  Patrick J Bolan; Eunhee Kim; Benjamin A Herman; Gillian M Newstead; Mark A Rosen; Mitchell D Schnall; Etta D Pisano; Paul T Weatherall; Elizabeth A Morris; Constance D Lehman; Michael Garwood; Michael T Nelson; Douglas Yee; Sandra M Polin; Laura J Esserman; Constantine A Gatsonis; Gregory J Metzger; David C Newitt; Savannah C Partridge; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2016-12-16       Impact factor: 4.813

Review 2.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

Review 3.  Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

Authors:  Reza Fardanesh; Maria Adele Marino; Daly Avendano; Doris Leithner; Katja Pinker; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2019-03-07       Impact factor: 4.813

4.  High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer.

Authors:  Lisa Singer; Lisa J Wilmes; Emine U Saritas; Ajit Shankaranarayanan; Evelyn Proctor; Dorota J Wisner; Belinda Chang; Bonnie N Joe; Dwight G Nishimura; Nola M Hylton
Journal:  Acad Radiol       Date:  2011-12-22       Impact factor: 3.173

Review 5.  In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients.

Authors:  Uma Sharma; Hyeon Man Baek; Min Ying Su; Naranamangalam R Jagannathan
Journal:  NMR Biomed       Date:  2011-01-28       Impact factor: 4.044

6.  Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis.

Authors:  Renu M Stephen; Abhinav K Jha; Denise J Roe; Theodore P Trouard; Jean-Philippe Galons; Matthew A Kupinski; Georgette Frey; Haiyan Cui; Scott Squire; Mark D Pagel; Jeffrey J Rodriguez; Robert J Gillies; Alison T Stopeck
Journal:  Magn Reson Imaging       Date:  2015-08-15       Impact factor: 2.546

7.  Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit.

Authors:  Mitsuhiro Tozaki; Katsuya Maruyama
Journal:  J Oncol       Date:  2010-09-26       Impact factor: 4.375

Review 8.  Diffusion MRI in early cancer therapeutic response assessment.

Authors:  C J Galbán; B A Hoff; T L Chenevert; B D Ross
Journal:  NMR Biomed       Date:  2016-01-15       Impact factor: 4.044

9.  High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response.

Authors:  Lisa J Wilmes; Rebekah L McLaughlin; David C Newitt; Lisa Singer; Sumedha P Sinha; Evelyn Proctor; Dorota J Wisner; Emine U Saritas; John Kornak; Ajit Shankaranarayanan; Suchandrima Banerjee; Ella F Jones; Bonnie N Joe; Nola M Hylton
Journal:  Acad Radiol       Date:  2013-05       Impact factor: 3.173

Review 10.  Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy.

Authors:  Jeon-Hor Chen; Min-Ying Su
Journal:  Biomed Res Int       Date:  2013-06-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.